Search for Clinical Trial Results

Sponsored By

Osteitis Deformans - 14 Studies Found

Status Study
Recruiting Study Name: Pathophysiology of Paget's Disease of Bone
Condition: Paget's Disease of Bone
Date: 2016-06-13
Completed Study Name: A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)
Condition: Paget's Disease of Bone
Date: 2007-05-30
Interventions: Drug: alendronate Duration of Treatment : 6 Months O
Completed Study Name: Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period
Condition: Paget's Disease of Bone
Date: 2003-01-14
Interventions:
  • Drug: Zoledronic Acid Zoledron
Completed Study Name: Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)
Condition: Paget's Disease of Bone
Date: 2008-10-15
Interventions: Drug: Zoledronic acid 5mg, i.v. single dose
Active, not recruiting Study Name: Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance −
Condition: Osseous Paget's Disease
Date: 2014-04-03
Interventions: Drug: Sodium risedronate Sodium risedronate tablets
Completed Study Name: Genetic Study of Families Affected by Paget's Disease of Bone
Condition: Paget's Disease of Bone
Date: 2008-09-05
Completed Study Name: 18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of Bone
Condition: Paget's Disease of Bone
Date: 2006-03-20
Interventions: Drug: Bisphosphonate treatment
Completed Study Name: Re-treatment of Patients With Paget's Disease Using Zoledronic Acid
Condition: Paget's Disease of the Bone
Date: 2008-08-21
Interventions: Drug: Zoledronic Acid Zoledronic acid 5 mg intravenous infusion once
Recruiting Study Name: Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
Condition:
  • Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia
  • Date: 2011-01-26
Completed Study Name: Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Condition:
  • Paget's Disease of the Bone
  • Hypocalcemia

Date: 2008-04-22
Interventions:
  • Drug: Reclast (ZOL446, zoledronic acid)

Next >>>